“cjc 1295 (NO DAC) + ipamorelin and GHK-Cu”
A user asks about combining CJC-1295 (no DAC) and Ipamorelin with GHK-Cu, likely seeking input on whether the GH-secretagogue stack and the copper peptide make sense together and how each is dosed.
Community reports — not medical advice
These are community-reported observations, not clinical recommendations, and have not been verified by medical professionals. Do not use them as the basis for any health decisions.
Notable threads from Reddit and peptide forums, grouped by theme. Filter by category, sentiment, or peptide to find what is relevant to you.
How the community is running peptides: doses, stacks, cycles, routes.
A user asks about combining CJC-1295 (no DAC) and Ipamorelin with GHK-Cu, likely seeking input on whether the GH-secretagogue stack and the copper peptide make sense together and how each is dosed.
A multi-compound stack thread covering IGF-1 LR3, glutathione, the CJC-1295 plus Ipamorelin combo, and the KLOW blend (KPV, GHK-Cu, BPC-157, TB-500), likely asking how to sequence or dose the full protocol.
A five-month personal progress update on GHK-Cu use, sharing the poster's ongoing experience with the copper peptide over an extended timeframe for others following similar protocols.
A TRT user on 120mg weekly testosterone asks whether switching to daily subcutaneous injections would help manage rising haematocrit and oestradiol, while also running retatrutide, cagrilintide, GHK-Cu, and 5-Amino-1MQ alongside training and a calorie deficit.
A crosspost in an Australian TRT subreddit: the poster asks whether daily subcutaneous testosterone dosing would help manage climbing haematocrit and oestradiol while stacking retatrutide, cagrilintide, GHK-Cu, and 5-Amino-1MQ with weight training and a strict diet.
Reported adverse experiences and safety concerns.
A user reports headaches after using the GLOW blend of GHK-Cu, BPC-157, and TB-500 and asks whether others have experienced the same. The thread is a self-reported side-effect inquiry.
A cross-posted report of headaches after using the GLOW blend of GHK-Cu, BPC-157, and TB-500. The poster asks whether this is a known reaction among other users.
A user describes accidentally administering far more of the KLOW peptide blend (BPC-157, TB-500, GHK-Cu, KPV) than intended and seeks input on what to expect after the overdose.
A user reports that the KLOW blend, which combines GHK-Cu, BPC-157, TB-500, and KPV, causes more welting and injection-site pain than GHK-Cu by itself, and asks whether others see the same reaction.
A user reports a reaction to GHK-Cu and asks the community for tips on what to do. The thread concerns adverse responses to the copper peptide, likely injection-site or skin-related, and how others have managed them.
Community discussion of studies and data.
A comparison of the KLOW and GLOW peptide blends, explaining how adding KPV to the GHK-Cu, BPC-157, and TB-500 base shifts what the combination is meant to address.
An explainer post reviewing the research behind peptides discussed for injury recovery, covering BPC-157, TB-500, Cartalax, and GHK-Cu. It summarizes mechanisms and the state of the evidence for each.
An explainer-style discussion of popular multi-peptide stacks — Wolverine (BPC-157 plus TB-500), GLOW, and KLOW (adding GHK-Cu and KPV) — examining what research exists on each component and what stacking is claimed to do.
An explainer on the GLOW 50/10/10 blend (GHK-Cu, BPC-157, TB-500) and how the KLOW variant adds KPV, reviewing what published research on each component actually shows versus community claims.
An explainer-style post in a Philippines biohacking community covering GHK-Cu, the copper peptide discussed for skin and tissue-repair applications, summarizing what community members and available literature report about its mechanisms and uses. Community synthesis, not clinical evidence.
Other community conversation.
A second same-week r/Biohacking thread reporting strong satisfaction with GHK-Cu, reinforcing a cluster of positive user sentiment around the copper peptide; specifics of use and outcomes remain anecdotal.
An enthusiastic endorsement thread praising GHK-Cu, part of a visible wave of positive GHK-Cu anecdotes in biohacking communities this week; the strong framing is anecdotal and unaccompanied by controlled evidence.
A general discussion thread on GHK-Cu, the copper-binding tripeptide widely discussed for skin and cosmetic applications. The bare title suggests an open question or experience-sharing prompt; GHK-Cu remains one of the most frequently raised compounds in biohacking communities despite most human data coming from topical cosmetic studies.